HORIZON (OP-106): An exploratory analysis of time-to-next treatment (TTNT) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) who received melflufen plus dexamethasone (dex) Meeting Abstract
| Authors: | Mateos, M. V.; Oriol, A.; Larocca, A.; Blade, J.; Cavo, M.; Otero, P. R.; Leleu, X.; Hiemenz, J. W.; Hassoun, H.; Touzeau, C.; Alegre, A.; Paner, A.; Maisel, C.; Mazumder, A.; Raptis, A.; Harmenberg, J.; Zavisic, S.; Thuresson, S.; Ohman, O.; Richardson, P. G. |
| Abstract Title: | HORIZON (OP-106): An exploratory analysis of time-to-next treatment (TTNT) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) who received melflufen plus dexamethasone (dex) |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368307493 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.e20570 |
| Notes: | Meeting Abstract: e20570 -- Source: Wos |
